UA55362U - Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle - Google Patents

Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle

Info

Publication number
UA55362U
UA55362U UAU201007175U UAU201007175U UA55362U UA 55362 U UA55362 U UA 55362U UA U201007175 U UAU201007175 U UA U201007175U UA U201007175 U UAU201007175 U UA U201007175U UA 55362 U UA55362 U UA 55362U
Authority
UA
Ukraine
Prior art keywords
treatment
felodipine
impairment
heart disease
left ventricle
Prior art date
Application number
UAU201007175U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201007175U priority Critical patent/UA55362U/en
Publication of UA55362U publication Critical patent/UA55362U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for assessing the efficacy of Felodipine in the treatment of the ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of the impairment of diastolic function of the left ventricle provides for the comparison of the state of the patients prior to and after the treatment. Prior to the treatment, Doppler echocardiography at rest is performed, and transmitral blood flow is assessed by measuring the rate of the early diastolic filling. The similar examination is performed after the course of the treatment. When the rate of the early diastolic filling increases by at least 15 % as compared with that prior to the treatment, the hemodynamic and antianginal effects of the treatment are regarded as positive.
UAU201007175U 2010-06-10 2010-06-10 Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle UA55362U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201007175U UA55362U (en) 2010-06-10 2010-06-10 Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201007175U UA55362U (en) 2010-06-10 2010-06-10 Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle

Publications (1)

Publication Number Publication Date
UA55362U true UA55362U (en) 2010-12-10

Family

ID=50738978

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201007175U UA55362U (en) 2010-06-10 2010-06-10 Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle

Country Status (1)

Country Link
UA (1) UA55362U (en)

Similar Documents

Publication Publication Date Title
UA55362U (en) Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA55363U (en) Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA59416U (en) Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA56814U (en) Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA54819U (en) Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA100786U (en) Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA100785U (en) Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
UA71709U (en) Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA101654U (en) Method for assessment of olmesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA55367U (en) Method for assessing efficacy of lacidipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA65049U (en) method for estimation of efficiency of treatment with TIMOLOL of patients with ischemic heart disease with angina pectoris and arterial hypertensy and disorder of diastolic function of the left ventricle by «hypertrophic» type
UA71695U (en) Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA91678U (en) Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA62810U (en) Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA61981U (en) method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61054U (en) method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA71708U (en) Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA71706U (en) Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA80784U (en) Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA55225U (en) method for assessment of treatment efficiency WITH BENAZEPRIL for patients with ischemic heart disease with angina pectoris and arterial hypertension with disturbance of left ventricle diastolic function by "hypertrophic" type